Your Trusted Commercialization Partner
for Cancer, Rare, and Complex Conditions

Our specialty pharmacy and patient support services work together to create a seamless patient experience. With a strong foundation in oncology and a deep expansion into rare and complex diseases, our approach is built on decades of commercialization expertise, high-touch patient care, advanced data reporting, and nationwide distribution.

CONTACT US

What Sets Us Apart?

Onco360 – Oncology and Hematology Specialty Pharmacy

CareMed – Rare and Orphan Specialty Pharmacy

  • Our robust portfolio of limited distribution drug launches demonstrates our unmatched experience as a successful launch partner.
  • Our commitment to quality and service has earned Onco360 a patient satisfaction score (NPS) of 98* and an NPS for CareMed of 100** from MMIT.
  • Precise, real-time data reporting and analytics through customized pharma portals that include drug-level details for prescription status, clinical insights, and patient outcomes.
  • Dedicated care teams, 24/7 support, and proactive adherence programs developed by Board-Certified Oncology and Specialty Pharmacists.
  • Dedicated financial advocacy team, of over 30 associates, has sourced millions in third-party assistance for eligible patients to help eliminate the potential financial burden of high out-of-pocket prescription costs.

ConnectMed360
– Patient Support Services

  • Personalized Patient Services Including:
    Prior authorization/appeal support
    Patient Assistance Programs including Quick Start, Bridge, and Free Drug Programs, vouchers, and starter kits
    Disease education, nursing, social behavioral support, and nutrition counseling
    Non-commercial pharmacy dispensing across 50 states (including Puerto Rico and Guam)
  • Dynamic Data Analytics and Insights.
    Customized, real-time portal development delivering a 360-degree view of the patient journey
    Access to de-identified data
    Comprehensive metrics and KPIs to drive business outcomes

Contact us to find out how we can support your program.

Name(Required)

*Third-party survey data provided by MMIT. Report date Q3 2025.
**Third-party survey data provided by MMIT. Report date Q4 2025.